|Publication number||US5318523 A|
|Application number||US 08/090,309|
|Publication date||Jun 7, 1994|
|Filing date||Jul 13, 1993|
|Priority date||Jul 13, 1993|
|Also published as||DE4325177A1|
|Publication number||08090309, 090309, US 5318523 A, US 5318523A, US-A-5318523, US5318523 A, US5318523A|
|Original Assignee||Lu Jieh Shan|
|Export Citation||BiBTeX, EndNote, RefMan|
|Patent Citations (7), Referenced by (39), Classifications (9), Legal Events (2)|
|External Links: USPTO, USPTO Assignment, Espacenet|
The present invention relates to a drug-feeder for children. The front end of the drug-feeder is disposed with a rotating member which is rotarily adjustable for optionally injecting the drug in an upward direction and or two lateral directions to cure the different areas in the oral cavity of a child so as to achieve the best curing effect. The drug-feeder has a drug guider and a drug chamber downward inclinedly connected to the drug guider to include an angle about 130 degree between them so that when the drug-feeder is Placed in the mouth of the child, the oral cavity of the child can be still clearly seen to facilitate the feeding of drug.
When a child is sick and needs medical treatment, an oral liquid medicine is currently most widely used one. With respect to a child, it is often difficult to accomplish the drug feeding. Therefore, a drug-feeder for a child has been developed for eliminating the trouble caused during feeding the child an oral liquid drug with a spoon. Although such conventional drug-feeder can eliminate the shortcoming that the child will resist the drug feeding due to the taste of the drug, the conventional drug-feeder still cannot completely avoid the drops of drug from incidentally dropping onto the tongue of the child. Moreover, to avoid the child from being choked by the drug, the child is often properly laid inclinedly when being fed with the conventional drug-feeder properly downward inclinedly positioned above the tongue of the child. At this point, the drug in the feeder will usually gradually drop out of the drug-feeder as shown in FIG. 7. As a result, the child will more or less taste the drug and resist the drug feeding. In addition, when the conventional drug-feeder is placed in the mouth of the child, the sight of the oral cavity of the child is obstacled by the drug-feeder and the areas needing cure cannot be clearly seen and thus the curing effect is inversely affected.
It is therefore a primary object of the present invention to provide a drug-feeder for children which can effectively eliminate the shortcoming of the conventional drug-feeder and prevent the drug in the drug-feeder from gradually and undesirably dropping onto the tongue of the child before the drug-feeder reaches the areas needing cure when it is in an inclined position in the mouth of the child; in addition, the drug guider and the drug chamber of the drug-feeder are properly downward inclinedly connected, permitting the oral cavity of the child to be clearly seen even when the drug-feeder is Placed in the mouth so as to facilitate the drug feeding.
It is a further object of the Present invention to provide the above drug-feeder Provided with a rotating member which can be rotarily adjusted to optionally inject the drug upward or laterally for achieving the best curing effect on different areas of the oral cavity of the child.
The structure, features, and other objects of the present invention and the technical means adopted by the present invention to achieve the objects thereof can be best understood through the following description of the preferred embodiments and the accompanying drawings, wherein:
FIG. 2 is an exploded view according to FIG. 1;
FIG. 3 includes a top view and a longitudinally sectional view of the present invention;
FIG. 4 shows the application of the Present invention;
FIG. 5 shows that the liquid drug in the drug-feeder of the present invention is injected upward in one single direction;
FIG. 6 shows that the liquid drug in the drug-feeder of the present invention is injected laterally in two directions; and
FIG. 7 shows the application of a conventional drug-feeder.
Please refer to FIG. 1. The drug-feeder 1 of the present invention is mainly composed of a drug chamber 2 for containing a liquid drug 3 therein and a drug guider 11 connected to the front of the drug chamber 2. A front end of the drug guider 11 is disposed with a rotating member 12. The rotation of the rotating member 12 Permits the drug-feeder 1 to optionally upward inject the drug in a single direction or horizontally inject the drug in two lateral directions.
Please now refer to FIGS. 2 and 3. The drug guider 11 is substantially a long and flat tube having an elliptical cross-section. The rotating member 12 is formed with an upward inclined tunnel 123, a Y-shaped tunnel 124, and an upper adjusting recess 121, whereby when an end opening 1211 of the recess 121 formed on the outer Periphery of the rotating member 12 is adjusted toward the front end of the drug-feeder 1 , the Y-shaped tunnel 124 becomes communicable with an inner guide tube 113 in the drug chamber 2, permitting the liquid drug 3 therein to be transferred through a flow passage 114 of the drug guider 11 and the Y-shaped tunnel 124 and then injected outward from two horizontal injecting orifices 14 formed on two sides of the front end of the drug guider 11, while when the opening 1211 of the recess 121 is adjusted reversely, the upward inclined tunnel 123 becomes communicable with the flow passage 114 so that the liquid drug 3 is transferred through the flow passage 114 and the tunnel 123 and then injected outward from an upper injecting orifice 122 at one end of the upward inclined tunnel 123. Accordingly, the liquid drug 3 can be optionally injected toward different areas in the oral cavity to achieve optimal medical treatment effects.
An arcuate stopper 13 is integrally formed under the drug guider 11, whereby when the drug guider 11 is extended into the mouth of a child for feeding the drug, the arcuate stopper 13 can abut against the lower lip and chin of the child and Prevents the drug guider 11 from excessively extending into the mouth and thus injuring the throat of the child. A coupling Portion 15 is integrally formed behind the arcuate stopper 13 to downward incline therefrom such that there is an angle about 130 degrees formed between the drug guider 11 and the coupling portion 15 and to couple with the drug chamber 2. A first and a second check valves 111, 112 are disposed in the coupling portion 15, wherein the first check valve 111 permits the air to irreversibly enter the drug chamber 2, while the second check valve 112 Permits the liquid drug 3 to irreversibly flow through the guide tube 113 and the flow passage 114. A weight member 115 is disposed at a lower end of the guide tube 113 opposite to the second check valve 112, permitting all the liquid drug 3 in the drug chamber 2 to be transferred outward through the guide tube 113 and the flow passage 114 to the tunnel 123 or 124. The drug chamber 2 can be made of transparent silicone resin or rubber and marked with scales for accurate]y dispensing the drug.
According to the above arrangement, when the drug-feeder of the present invention is Placed into the mouth of a child, no liquid drug 3 will undesirably drop onto the tongue of the child to make the child taste the drug before the drug guider 11 reaches the the normal feeding position and thus resists the drug feeding as shown in FIG. 7. Moreover, the drug can be optionally injected upward or laterally to oure the uvula 41 or tonsil 42, respectively, for achieving the best curing effect.
It is to be understood that the form of the present invention shown and disclosed is to be taken as a preferred embodiment of the Present invention and that various changes in the shape, size and arrangement of parts may be resorted to without departing from the spirit of the present invention or the scope of the subjoined claims.
|Cited Patent||Filing date||Publication date||Applicant||Title|
|US3572337 *||Dec 26, 1968||Mar 23, 1971||George J Schunk||Syringe for oral administration of medicine|
|US4405321 *||Feb 26, 1982||Sep 20, 1983||Budoff Penny W||Douche delivery device|
|US4519794 *||Oct 11, 1983||May 28, 1985||Sneider Vincent R||Valve control of nozzle flow from disposable syringe|
|US4880409 *||Mar 31, 1987||Nov 14, 1989||Hakan Bergkvist||Feeding device|
|US4966312 *||Dec 6, 1988||Oct 30, 1990||Waring Donald A||Disposable oral liquid measure dispenser|
|US5222940 *||Jan 3, 1992||Jun 29, 1993||Wilk Peter J||Device for facilitating administration of medicine|
|US5236415 *||Feb 28, 1992||Aug 17, 1993||Stallings Ronald V||Drinking straw for ingesting unpalatable liquids and method of use|
|Citing Patent||Filing date||Publication date||Applicant||Title|
|US5507278 *||Nov 18, 1994||Apr 16, 1996||Karell; Manuel L.||Tongue-guard for inhaler|
|US5685291 *||Nov 15, 1996||Nov 11, 1997||Marsh; Jean Ann||Nebulizer adapter system for premature babies|
|US5692493 *||Mar 8, 1996||Dec 2, 1997||Diemolding Corporation||Tongue Protector|
|US6083430 *||Apr 29, 1996||Jul 4, 2000||Fuisz Technologies Ltd.||Method of preparing a dosage unit by direct tableting and product therefrom|
|US7727246||Dec 6, 2001||Jun 1, 2010||Ethicon Endo-Surgery, Inc.||Methods for endoluminal treatment|
|US7900637||Jun 24, 2002||Mar 8, 2011||Niconovum Ab||Device and method for the administration of a substance|
|US8021320||Feb 18, 2009||Sep 20, 2011||Portaero, Inc.||Self-sealing device and method for delivery of a therapeutic agent through a pneumostoma|
|US8062314||Dec 7, 2006||Nov 22, 2011||Ethicon Endo-Surgery, Inc.||Methods for the endoluminal treatment of gastroesophageal reflux disease (GERD)|
|US8231581||Jan 25, 2011||Jul 31, 2012||Portaero, Inc.||Enhanced pneumostoma management device and methods for treatment of chronic obstructive pulmonary disease|
|US8252003||Feb 18, 2009||Aug 28, 2012||Portaero, Inc.||Surgical instruments for creating a pneumostoma and treating chronic obstructive pulmonary disease|
|US8430094||Feb 18, 2009||Apr 30, 2013||Portaero, Inc.||Flexible pneumostoma management system and methods for treatment of chronic obstructive pulmonary disease|
|US8453637||Feb 18, 2009||Jun 4, 2013||Portaero, Inc.||Pneumostoma management system for treatment of chronic obstructive pulmonary disease|
|US8475389||Jun 8, 2010||Jul 2, 2013||Portaero, Inc.||Methods and devices for assessment of pneumostoma function|
|US8491602||Feb 18, 2009||Jul 23, 2013||Portaero, Inc.||Single-phase surgical procedure for creating a pneumostoma to treat chronic obstructive pulmonary disease|
|US8506577||Jul 6, 2012||Aug 13, 2013||Portaero, Inc.||Two-phase surgical procedure for creating a pneumostoma to treat chronic obstructive pulmonary disease|
|US8518053||Feb 11, 2010||Aug 27, 2013||Portaero, Inc.||Surgical instruments for creating a pneumostoma and treating chronic obstructive pulmonary disease|
|US8741348||Dec 19, 2003||Jun 3, 2014||Niconovum Ab||Physically and chemically stable nicotine-containing particulate material|
|US8821435||Sep 6, 2009||Sep 2, 2014||Haim Hazan||Device for administering medicine|
|US8926557 *||Nov 12, 2012||Jan 6, 2015||Amcor Limited||Fluid dispenser with tongue depressor|
|US9402809||Mar 16, 2007||Aug 2, 2016||Niconovum Usa, Inc.||Snuff composition|
|US9629832||Apr 28, 2014||Apr 25, 2017||Niconovum Usa, Inc.||Physically and chemically stable nicotine-containing particulate material|
|US20020078967 *||Dec 6, 2001||Jun 27, 2002||Robert Sixto||Methods for the endoluminal treatment of gastroesophageal reflux disease (GERD)|
|US20020138086 *||May 20, 2002||Sep 26, 2002||Robert Sixto||Surgical clips particularly useful in the endoluminal treatment of gastroesophageal reflux disease (GERD)|
|US20040191322 *||Dec 19, 2003||Sep 30, 2004||Henri Hansson||Physically and chemically stable nicotine-containing particulate material|
|US20080207995 *||Mar 26, 2007||Aug 28, 2008||Ethicon Endo-Surgery, Inc.||Surgical clip application assembly|
|US20090205658 *||Feb 18, 2009||Aug 20, 2009||Portaero, Inc.||Devices and methods for delivery of a therapeutic agent through a pneumostoma|
|US20090209906 *||Feb 18, 2009||Aug 20, 2009||Portaero, Inc.||Self-sealing device and method for delivery of a therapeutic agent through a pneumostoma|
|US20090209970 *||Feb 18, 2009||Aug 20, 2009||Portaero, Inc.||Single-phase surgical procedure for creating a pneumostoma to treat chronic obstructive pulmonary disease|
|US20100045702 *||Feb 18, 2009||Feb 25, 2010||Noregin Assets N.V., L.L.C.||Navigating Digital Images using Detail-in-context Lenses|
|US20110180064 *||Feb 14, 2011||Jul 28, 2011||Portaero, Inc.||Methods and devices for follow-up care and treatment of a pneumstoma|
|US20130123690 *||Nov 12, 2012||May 16, 2013||Amcor Limited||Fluid dispenser with tongue depressor|
|CN104602651A *||Mar 28, 2013||May 6, 2015||特鲁德尔医学国际公司||Oral device with bolus simulator and method of use thereof|
|EP2242527A2 *||Feb 17, 2009||Oct 27, 2010||Portaero, Inc.||Devices and methods for delivery of a therapeutic agent through a pneumostoma|
|EP2242527A4 *||Feb 17, 2009||Jul 13, 2011||Portaero Inc||Devices and methods for delivery of a therapeutic agent through a pneumostoma|
|EP2830548A4 *||Mar 28, 2013||Jan 20, 2016||Trudell Medical Int||Oral device with bolus simulator and method of use thereof|
|EP2982349A1 *||Mar 28, 2013||Feb 10, 2016||Trudell Medical International||Oral device and method for use thereof|
|WO2003000324A1 *||Jun 24, 2002||Jan 3, 2003||Tostop Ab||Device and method for the administration of a substance|
|WO2005061032A1||Mar 12, 2004||Jul 7, 2005||Becton Dickinson And Company||Safety shield system for prefilled syringe|
|WO2010026586A1 *||Sep 6, 2009||Mar 11, 2010||Haim Hazan||A device f r administerin medicine|
|U.S. Classification||604/77, 604/516|
|International Classification||A61M11/02, A61J7/00|
|Cooperative Classification||A61J7/0053, A61M2210/065, A61M11/02|
|European Classification||A61M11/02, A61J7/00D10|
|Jun 7, 1998||LAPS||Lapse for failure to pay maintenance fees|
|Sep 22, 1998||FP||Expired due to failure to pay maintenance fee|
Effective date: 19980607